BRAF and colorectal carcinoma: In sporadic colorectal carcinomas displaying the MSI phenotype, MLH1 hypermethylation and BRAF p.V600E mutations frequently co-occur, indicating a possible causal relationship between BRAF mutations and MLH1 loss [127,128,129].